RxDoctor Payments Data

Curtis Page, MD

Family Medicine · Tempe, AZNPI 1295730539

Payments from drug & device makers

$15,917in general payments, 2019–2025

Across 627 payments — averaging $25.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$7K
  • AbbVie$1K
  • AstraZeneca$874
  • Boehringer Ingelheim$834
  • Pfizer$671
  • Novo Nordisk$592
  • plus $5K from 54 others

What the payments were for

  • Consulting fees$5,25033%
  • Travel & lodging$6324%
  • Food & beverage$9,97763%
  • Education$410%
  • Entertainment$180%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Lilly USA, LLC62$6,655
AbbVie(2 entities)148$1,480
AstraZeneca32$874
Boehringer Ingelheim42$834
Pfizer36$671
Novo Nordisk38$592
GSK32$553
Novartis32$440
Mylan Specialty L.p.22$364
Amgen16$260
Eisai Inc.10$258
Bayer10$170
Abbott9$169
Sanofi-aventis U.S. LLC11$164
Dexcom, Inc.7$123
Lucid Diagnostics Inc.3$116
Boston Scientific6$115
Vanda Pharmaceuticals Inc.7$109
Indivior Inc.6$107
Merck6$98
Takeda Pharmaceuticals U.S.A., Inc.7$97
Teva Pharmaceuticals USA, Inc.6$93
Viatris Specialty LLC5$87
Sumitomo Pharma America, Inc.4$86
Astellas Pharma US Inc3$71
Corcept Therapeutics4$68
Nestle Healthcare Nutrition Inc.3$64
Topcon Healthcare Solutions, Inc.1$63
Protega Pharmaceutials Inc1$63
Medtronic(2 entities)2$59
Inspire Medical Systems, Inc.3$53
Sunovion Pharmaceuticals Inc.4$53
Ironwood Pharmaceuticals, Inc3$52
Tactile Systems Technology Inc1$48
Braeburn Inc.2$46
Phadia US Inc.2$45
Kowa Pharmaceuticals America, Inc.3$41
Lundbeck LLC2$40
Regeneron Healthcare Solutions, Inc.2$39
Sanofi Pasteur Inc.2$39
Johnson & Johnson3$34
Gilead2$33
Verona Pharma, Inc.1$33
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC2$31
Amarin Pharma, Inc.2$29
Aimmune Therapeutics, Inc.1$27
Alkermes, Inc.1$26
C2n Diagnostics, LLC1$25
Pharmacosmos Therapeutics Inc.1$25
Canon Medical Systems USA, Inc.1$22
Orexo US, Inc.1$22
BETA Bionics, Inc.1$21
Angiodynamics, Inc.1$20
Verity Pharmaceuticals Inc.1$20
Optos, Inc.1$18
Esperion Therapeutics, Inc.1$18
Biohaven Pharmaceuticals, Inc.1$17
Idorsia Pharmaceuticals US Inc1$16
Ascensia Diabetes Care US Inc.1$15
Inogen, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,917 in reported general payments places this provider in the 95th percentile of 2,099 family medicine providers in Arizona.

See all family medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$556,618
Medicare patients
625
Services billed
25,127

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol234$234,000
MounjaroTirzepatide129$153,397
EliquisApixaban131$127,582
OzempicSemaglutide59$71,309
Trelegy ElliptaFluticasone/Umeclidin/Vilanter50$53,177
Soliqua 100-33Insulin Glargine/Lixisenatide55$49,405
JardianceEmpagliflozin41$43,896
KerendiaFinerenone20$33,190
TrulicityDulaglutide25$30,725
Stiolto RespimatTiotropium Br/Olodaterol Hcl35$27,287
GlyxambiEmpagliflozin/Linagliptin22$22,566
ProliaDenosumab11$18,790
XareltoRivaroxaban22$18,627
EntrestoSacubitril/Valsartan17$16,774
RybelsusSemaglutide17$15,877

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$874$244,003248 claims
Lilly USA, LLCMounjaro, Trulicity$6,655$184,121154 claims
PfizerEliquis$671$127,582131 claims
Novo NordiskOzempic, Rybelsus, Wegovy$592$101,40987 claims
Boehringer IngelheimJardiance, Stiolto Respimat, Glyxambi$834$93,74898 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$553$76,70289 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$164$49,40555 claims
BayerKerendia$170$33,19020 claims
AmgenProlia$260$18,79011 claims
Johnson & JohnsonXarelto$34$18,62722 claims
NovartisEntresto$440$16,77417 claims
Astellas Pharma US IncMyrbetriq$71$7,72314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,099 family medicine providers in Arizona.

Other family medicine in Tempe

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →